Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Queensland Health
Fish and Richardson
Deloitte
Cerilliant
Covington
Express Scripts
Baxter

Generated: November 13, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Sandoz

« Back to Dashboard

Sandoz Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Sandoz Inc pregabalin 091229 225MG CAPSULE; ORAL
Sandoz Inc maraviroc 203382 300MG TABLET;ORAL
Sandoz Inc treprostinil 203649 1MG/ML INJECTABLE;INJECTION
Sandoz Inc lisdexamfetamine dimesylate 202836 60MG CAPSULE;ORAL
Sandoz Inc caspofungin acetate 200833 50MG/VIAL INJECTABLE; INJECTION
Sandoz Inc maraviroc 203382 150MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Julphar
US Army
Dow
McKesson
Boehringer Ingelheim
Cipla
Colorcon
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.